Levodopa and Carbidopa Controlled Release Matrix Tablets
Now:
AED 222.00 Inclusive of VAT
Free Delivery
Get it by 8 - 11 Feb
Earn 5% cashback with the Mashreq noon Credit Card. Apply now
1
Free delivery on Lockers & Pickup Points
Learn more
Enjoy hassle free returns with this offer.
Item as Described
70%
Partner Since
7+ YearsSpecifications
| Publisher | LAP Lambert Academic Publishing |
| ISBN 13 | 9783838348117 |
| ISBN 10 | 3838348117 |
| Author | Jagan Mohan Somagoni |
| Language | English |
| Book Description | In recent years, in association with progress and innovation in the field of pharmaceutical technology, there has been an increasing effort to develop prolonged release dosage forms for many drugs. Correspondingly, a growing number of new prolonged release dosage forms have been submitted for regulatory approval. Prolonged release dosage forms have many advantages in safety and efficacy over immediate release drug products in that the frequency of dosing can be reduced, drug efficacy can be prolonged and the incidence and/or intensity of adverse effects can be decreased. However, some prolonged release dosage forms have less clear rationale or are developed for active ingredients which are not appropriate for prolonged release dosage forms. In other cases, prolonged release dosage forms are designed without full consideration of the basic properties of the drugs. Moreover, standards for dissolution tests, which are important for evaluating prolonged release dosage forms, have not appropriately been established. As a result, it is often difficult to evaluate whether a prolonged release dosage form is acceptable or not. |
| Publication Date | 7 May 2010 |
| Number of Pages | 72 pages |
Levodopa and Carbidopa Controlled Release Matrix Tablets
Added to cart
Cart Total AED 222.00
